High-Cost Drugs
High-Cost Drug Risk Is Now a Business Risk.
High Cost Specialty Drugs & Benefit Plan Sustainability
Over the past decade, high-cost specialty medications have become the largest driver of benefit plan inflation in Canada.
These medications are commonly used to treat conditions such as:
- Rheumatoid arthritis
- Crohn’s disease
- Psoriasis
- Severe asthma
- Autoimmune disorders
While these medications can dramatically improve quality of life, many now cost $20,000 to $80,000+ per patient per year, and some exceed $150,000 annually.
For many employer benefit plans, a single claimant can dramatically impact premiums.
Example
A $60,000 drug claim can equal the annual cost of 15–25 employees on a typical benefits plan.
Because of this, employers across Canada are increasingly reviewing strategies to manage high-cost drug exposure while still ensuring employees receive the medications they need.
Access to Medication Support Programs
The good news is that most specialty medications are supported by manufacturer-funded patient assistance programs.
These programs help patients:
- Coordinate insurance coverage
- Access financial assistance
- Reduce or eliminate copayments
- Navigate provincial drug programs
- Access nursing and case management support
Employees who require these medications are strongly encouraged to contact the applicable support program.
Alberta Blue Cross Non-Group Coverage
In the summer of 2026, legislated changes to the Alberta Blue Cross Non-Group Drug Program will remove access to coverage for Albertans requiring extremely high-cost medications (as first payor). This means more risk to your benefit program.
WellnFlex has communicated these changes to all clients and can assist employers in navigating provincial coverage options if needed.
Managing Drug Claim Risk for Employers
Many employers are now implementing strategies such as:
- Annual drug maximums
- Managed specialty drug programs or formularies
- Case management for high-cost claims
These approaches help ensure:
- Employees continue to receive access to treatment
- Benefit plans remain financially sustainable
- Premium increases remain predictable
How WellnFlex Helps
WellnFlex works with employers to:
- Analyze high-cost drug exposure
- Model the financial impact of specialty drug claims
- Compare plan designs that reduce risk
- Ensure employees have access to assistance programs
If you would like to review how high-cost drugs may impact your benefit plan, our team would be happy to prepare an analysis.
Common High-Cost Drugs & Support Programs
High-cost specialty medications are becoming increasingly common across employer benefit plans.
Explore individual medications, learn about their associated patient support programs, and discover resources that may help patients navigate coverage and treatment.
Turn High-Cost Drug Risk into Predictable Planning
High-cost drug claims don’t have to create financial surprises for your benefit plan.
Wellnflex helps employers anticipate exposure, manage costs, and design sustainable, long-term strategies that keep your plan, and your organization, stable.
We focus on, high-cost drug exposure modeling, risk forecasting, claims volatility planning, plan sustainability design, catastrophic claim containment strategies, governance-based benefit structures, long-term cost engineering, renewal shock prevention
Your benefits are more than coverage, they’re a business asset.
We don’t react to claims, we design systems that absorb them. Let’s protect them together.